Key facts
- Turquoise Health’s last known valuation is $315.0M (Mar 2026).
- It has raised $95.2M across 3 recorded rounds; the latest was Early Stage VC ($30.0M) in Dec 2023.
- Notable investors include Andreessen Horowitz, Bessemer Venture Partners, BoxGroup, Tiger Global Management, Oak HC/FT — 11 tracked in total.
- Turquoise Health has filed 3 Form Ds with the SEC since 2021, most recently Jan 2024 ($30.0M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Turquoise Health
Funding rounds
3 roundsAbout Turquoise Health
Provider of healthcare information services intended to reduce the cost and complexity of healthcare by simplifying administration. The company's platform lets users browse and compare prices of the elective services offered by hospitals, price comparison between insurance services, and the option to browse by the procedure and provider, enabling individuals to save money on elective treatments by comparing prices and healthcare organizations and professionals to drive volume for both cash-paying and insured patients.
- Sector
- Information Technology
- HQ
- San Diego, CA, United States
- Founded
- 2020
- Employees
- 200
- Website
- turquoise.health/
- Ownership
- Privately Held (backing)
Turquoise Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Turquoise Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Turquoise Health in its N-PORT filings yet. We sweep new filings monthly.